Probiotic Ingredients Market Size, Share & Trends Analysis Report By Form (Dry/Powder, Liquid), By Ingredient (Bacteria, Yeast, Spore Formers), By Application, By End-user, By Region, And Segment Forecasts, 2022 - 2030

Probiotic Ingredients Market Size, Share & Trends Analysis Report By Form (Dry/Powder, Liquid), By Ingredient (Bacteria, Yeast, Spore Formers), By Application, By End-user, By Region, And Segment Forecasts, 2022 - 2030

Prebiotic Ingredients Market Growth & Trends

The global probiotic ingredients market size is expected to reach USD 5.33 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 8.8% from 2022 to 2030. The demand for probiotic ingredients is expected to grow owing to the rising awareness among people regarding maintaining overall health, wellness & nutrition, which in turn increases the demand for immunity-boosting products.

Bacillus coagulant, a spore-forming probiotic ingredient, is witnessing ascending demand from the food and beverages segment as it is used in a wide range of functional food and beverage products. The rising popularity of functional food & beverages among youngsters as well as the growing demand for probiotic ingredients in the animal feed industry will further boost the demand.

Probiotic bacteria strains are used in various end-use industries such as food & beverage, dietary supplements, and animal nutrition, among others. In order to produce healthy probiotic strains, it is important to produce them in a viable form and make them suitable for consumption. Some of the technologies used in the manufacturing of probiotic ingredients include spray drying, spray cooling, fluid-bed agglomeration & coating, freeze & vacuum drying, and emulsion-based techniques.

Preventive healthcare includes dietary choices and a healthy lifestyle that help to prevent the occurrence of diseases. Preventive healthcare awareness is growing as a result of a variety of factors, including rising disposable incomes, improved living standards, and the aging population. The easy availability of information about preventive healthcare on the internet is also helping to raise awareness. These factors are expected to contribute to the overall growth of the industry.

Europe is estimated to hold a substantial share of the global industry during the forecast period. Increasing awareness campaigns conducted by major organizations in Europe such as the International Scientific Association for Probiotics and Prebiotics (ISAPP) and the Europe International Probiotics Association (IPA) in various industries and institutions are propelling the regional industry growth.

Probiotic Ingredients Market Report Highlights

  • The dry/powder form segment held the largest revenue share in 2021 and is expected to grow steadily during the forecast period, owing to its ease of incorporation in various formulations and dosages as per consumer requirements
  • The bacteria ingredient segment accounted for the highest revenue share in 2021. This is due to the rising adoption of bacteria in application areas such as probiotic functional food & beverages and dietary supplements
  • Dietary supplements are expected to be the fastest-growing application segment during the forecast period, owing to the rising demand for preventive healthcare as a result of the immunity-boosting concept caused by the COVID-19 pandemic and the increased cost of healthcare services globally
  • The human probiotics end-user segment accounted for a significant market share in 2021 in terms of revenue, as a result of the evidence-backed benefits of consuming probiotic ingredients, especially in gut health
  • Asia Pacific is expected to register the highest CAGR during the forecast period. This is due to the rising demand for nutritional supplements in the region's most populous nations, such as India and China
  • Companies in the probiotic ingredients industry have been trying to increase their production capabilities and expand their geographic reach by entering into strategic partnerships, and mergers & acquisitions
Please note The report will be delivered in 4-8 business days upon order notification.


Chapter 1 Report Scope and Objectives
1.1 Market Segmentation
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Research Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
Chapter 2 Methodology
2.1 Research Methodology
2.1.1 Information procurement
2.1.2 Purchased Database
2.1.3 GVR’s Internal Database
2.1.4 Secondary Sources
2.1.5 Primary Research
2.2 Information or Data Analysis
2.2.1 Data Analysis Models
2.3 Market Formulation & Validation
2.4 Model Details
2.4.1 Commodity Flow Analysis
2.4.2 Volume price analysis
2.5 List of Secondary Sources
2.6 List of Abbreviations
Chapter 3 Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.2.1 Product
3.3 Regional Outlook
3.4 Competitive Insights
Chapter 4 Market Variables, Trends & Scope
4.1 Market Lineage Outlook
4.1.1 Parent Market Outlook
4.1.2 Related/Ancillary Market Outlook
4.2 Contraceptive Market Dynamics
4.2.1 Market Driver Analysis
4.2.1.1 Government and NGO initiatives to promote contraceptive methods
4.2.1.2 Increasing prevalence of unwanted pregnancies and rising number of women with unmet contraceptive drugs and devices needs
4.2.1.3 Increasing prevalence of sexually transmitted diseases (STDs)
4.2.2 Market Restraint Analysis
4.2.2.1 Rapidly aging population and rising prevalence of infertility
4.2.2.2 Adverse effects associated with the use of contraceptive drugs and devices
4.3 Contraceptive Market: Business Environment Analysis Tools
4.3.1 Porter’s Five Forces analysis
4.4 Penetration & Growth Prospect Mapping
4.5 Qualitative Analysis: Impact of COVID-19 on the Contraceptive Market
Chapter 5 Contraceptive Market: Product Analysis
5.1 Contraceptive Product Market Share Analysis, 2021 & 2030
5.2 Contraceptive Product Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2017 - 2030 for the Product Segment
5.3.1 Contraceptive Drugs
5.3.1.1 Contraceptive drugs market, 2017 - 2030 (USD Million)
5.3.1.2 Contraceptive Pills
5.3.1.2.1 Contraceptive pills market, 2017 - 2030 (USD Million)
5.3.1.3 Patch
5.3.1.3.1 Patch market, 2017 - 2030 (USD Million)
5.3.1.4 Injectables
5.3.1.4.1 Injectables market, 2017 - 2030 (USD Million)
5.3.2 Contraceptive Devices
5.3.2.1 Contraceptive devices market, 2017 - 2030 (USD Million)
5.3.2.2 Condoms
5.3.2.2.1 Condoms market, 2017 - 2030 (USD Million)
5.3.2.2.2 Male Condoms
5.3.2.2.2.1 Male condoms market, 2017 - 2030 (USD Million)
5.3.2.2.3 Female Condoms
5.3.2.2.3.1 Female condoms market, 2017 - 2030 (USD Million)
5.3.2.3 Subdermal Implants
5.3.2.3.1 Subdermal implants market, 2017 - 2030 (USD Million)
5.3.2.4 Intra-Uterine Devices (IUDs)
5.3.2.4.1 Intra-Uterine devices (IUDs) market, 2017 - 2030 (USD Million)
5.3.2.4.2 Copper IUDs
5.3.2.4.2.1 Copper IUDs market, 2017 - 2030 (USD Million)
5.3.2.4.3 Hormonal IUDs
5.3.2.4.3.1 Hormonal IUDs market, 2017 - 2030 (USD Million)
5.3.2.5 Vaginal Rings
5.3.2.5.1 Vaginal Rings market, 2017 - 2030 (USD Million)
5.3.2.6 Diaphragm
5.3.2.6.1 Diaphragm market, 2017 - 2030 (USD Million)
Chapter 6 Contraceptive Market: Regional Analysis
6.1 Contraceptive Regional Market Share Analysis, 2020 & 2030
6.2 Regional Market Snapshot
6.3 Market Size, & Forecasts, and Trend Analysis, 2017 to 2030
6.3.1 North America
6.3.1.1 North America Contraceptive Market, 2017 - 2030 (USD Million)
6.3.1.2 U.S.
6.3.1.2.1 U.S. Contraceptive Market, 2017 - 2030 (USD Million)
6.3.1.3 Canada
6.3.1.3.1 Canada Contraceptive Market, 2017 - 2030 (USD Million)
6.3.2 Europe
6.3.2.1 Europe Contraceptive Market, 2017 - 2030 (USD Million)
6.3.2.2 U.K.
6.3.2.2.1 U.K. Contraceptive Market, 2017 - 2030 (USD Million)
6.3.2.3 Germany
6.3.2.3.1 Germany Contraceptive Market, 2017 - 2030 (USD Million)
6.3.2.4 France
6.3.2.4.1 France Contraceptive Market, 2017 - 2030 (USD Million)
6.3.2.5 Italy
6.3.2.5.1 Italy Contraceptive Market, 2017 - 2030 (USD Million)
6.3.2.6 Spain
6.3.2.5.1 Spain Contraceptive Market, 2017 - 2030 (USD Million)
6.3.3 Asia Pacific
6.3.3.1 Asia Pacific Contraceptive Market, 2017 - 2030 (USD Million)
6.3.3.2 Japan
6.3.3.2.1 Japan Contraceptive Market, 2017 - 2030 (USD Million)
6.3.3.3 China
6.3.3.3.1 China Contraceptive Market, 2017 - 2030 (USD Million)
6.3.3.4 India
6.3.3.4.1 India Contraceptive Market, 2017 - 2030 (USD Million)
6.3.3.5 Australia
6.3.3.5.1 Australia Contraceptive Market, 2017 - 2030 (USD Million)
6.3.3.6 South Korea
6.3.3.6.1 South Korea Contraceptive Market, 2017 - 2030 (USD Million)
6.3.4 Latin America
6.3.4.1 Latin America Contraceptive Market, 2017 - 2030 (USD Million)
6.3.4.2 Mexico
6.3.4.2.1 Mexico Contraceptive Market, 2017 - 2030 (USD Million)
6.3.4.3 Brazil
6.3.4.3.1 Brazil Contraceptive Market, 2017 - 2030 (USD Million)
6.3.4.4 Argentina
6.3.4.4.1 Argentina Contraceptive Market, 2017 - 2030 (USD Million)
6.3.5 Middle East & Africa
6.3.5.1 Middle East & Africa Contraceptive Market, 2017 - 2030 (USD Million)
6.3.5.2 South Africa
6.3.5.2.1 South Africa Contraceptive Market, 2017 - 2030 (USD Million)
6.3.5.2 UAE
6.3.5.2.1 UAE Contraceptive Market, 2017 - 2030 (USD Million)
6.3.5.3 Saudi Arabia
6.3.5.3.1 Saudi Arabia Contraceptive Market, 2017 - 2030 (USD Million)
Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, by Key Market Participants
7.2 Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
7.3 Company Market Position Analysis
7.4 Company Profiles
7.4.1 ABBVIE INC.
7.4.1.1 Company overview
7.4.1.2 Financial performance
7.4.1.3 Product benchmarking
7.4.1.4 Strategic initiatives
7.4.2 BAYER AG
7.4.2.1 Company overview
7.4.2.2 Financial performance
7.4.2.3 Product benchmarking
7.4.2.4 Strategic initiatives
7.4.3 Organon Group Of Companies
7.4.3.1 Company overview
7.4.3.2 Financial performance
7.4.3.3 Product benchmarking
7.4.3.4 Strategic initiatives
7.4.4 PFIZER
7.4.4.1 Company overview
7.4.4.2 Financial performance
7.4.4.3 Product benchmarking
7.4.4.4 Strategic initiatives
7.4.5 AFAXYS, INC.
7.4.5.1 Company overview
7.4.5.2 Financial performance
7.4.5.3 Product benchmarking
7.4.5.4 Strategic initiatives
7.4.6 VIATRIS (MYLAN)
7.4.6.1 Company overview
7.4.6.2 Financial performance
7.4.6.3 Product benchmarking
7.4.6.4 Strategic initiatives
7.4.7 AGILE THERAPEUTICS
7.4.7.1 Company overview
7.4.7.2 Financial performance
7.4.7.3 Product benchmarking
7.4.7.4 Strategic initiatives
7.4.8 JANSSEN PHARMACEUTICALS, INC.
7.4.8.1 Company overview
7.4.8.2 Financial performance
7.4.8.3 Product benchmarking
7.4.8.4 Strategic initiatives
7.4.9 HELM AG
7.4.9.1 Company overview
7.4.9.2 Financial performance
7.4.9.3 Product benchmarking
7.4.9.4 Strategic initiatives
7.4.10 CHURCH & DWIGHT
7.4.10.1 Company overview
7.4.10.2 Financial performance
7.4.10.3 Product benchmarking
7.4.10.4 Strategic initiatives
7.4.11 Veru, Inc.
7.4.11.1 Company overview
7.4.11.2 Financial performance
7.4.11.3 Product benchmarking
7.4.11.4 Strategic initiatives
7.4.12 CHINA RESOURCES ZIZHU PHARMACEUTICAL CO., LTD. (CR ZIZHU)
7.4.12.1 Company overview
7.4.12.2 Financial performance
7.4.12.3 Product benchmarking
7.4.12.4 Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings